Advertisement
Screener

ACCENTIA BIOPHARMACEUTICALS INC Reorganization Items

ACCENTIA BIOPHARMACEUTICALS INC Reorganization Items

ACCENTIA BIOPHARMACEUTICALS INC reported Reorganization Items of $5.62 million for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.

Discontinued › Notes › Reorganizations › Reorganization Items

us-gaap:ReorganizationItems · last filed 2012-12-26

  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for the quarter ending 2012-09-30 was -$8.13K.
  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for the quarter ending 2012-06-30 was $5.07M, a 680.06% increase year-over-year.
  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for the quarter ending 2012-03-31 was -$368.71K.
  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for the quarter ending 2011-12-31 was -$184.68K.
  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for fiscal 2012 was $5.62M, a 54.55% decline from fiscal 2011.
  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for fiscal 2011 was $12.36M.
  • ACCENTIA BIOPHARMACEUTICALS INC reorganization items for fiscal 2010 was -$1.05M.
Period endReorganization Items 3 monthReorganization Items 3 month as first filedReorganization Items 6 monthReorganization Items 9 monthReorganization Items 9 month as first filedReorganization Items 12 monthReorganization Items 12 month as first filed
2012-09-30-$8.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26
$5.06M
derived: sum of 2 quarters · filed 2012-12-26
$4.69M
derived: sum of 3 quarters · filed 2012-12-26
$5.62M
10-K · filed 2012-12-26
2012-06-30$5.07M
10-Q · filed 2012-08-14
$4.70M
derived: sum of 2 quarters · filed 2012-08-14
$5.62M
10-Q · filed 2012-08-14
$4.43M
derived: sum of 4 quarters · filed 2012-12-26
2012-03-31-$368.71K
10-Q · filed 2012-05-15
-$553.39K
derived: sum of 2 quarters · filed 2012-05-15
-$636.37K
derived: sum of 3 quarters · filed 2012-12-26
$13.68K
derived: sum of 4 quarters · filed 2012-12-26
2011-12-31-$184.68K
10-Q · filed 2012-02-10
-$267.66K
derived: sum of 2 quarters · filed 2012-12-26
$382.39K
derived: sum of 3 quarters · filed 2012-12-26
-$388.52K
derived: sum of 4 quarters · filed 2012-12-26
2011-09-30-$82.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26
$567.07K
derived: sum of 2 quarters · filed 2012-12-26
-$203.84K
derived: sum of 3 quarters · filed 2012-12-26
$12.36M
10-K · filed 2012-12-26
-$12.36M
10-K · filed 2011-12-19
2011-06-30$650.05K
10-Q · filed 2012-08-14
-$650.05K
10-Q · filed 2011-08-12
-$120.86K
derived: sum of 2 quarters · filed 2012-08-14
$12.44M
10-Q · filed 2012-08-14
-$12.44M
10-Q · filed 2011-08-12
-$10.81M
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31-$770.91K
10-Q · filed 2012-05-15
-$11.79M
derived: sum of 2 quarters · filed 2012-05-15
-$11.46M
derived: sum of 3 quarters · filed 2012-05-15
-$11.25M
derived: sum of 4 quarters · filed 2012-05-15
2010-12-31-$11.02M
10-Q · filed 2012-02-10
-$10.69M
derived: sum of 2 quarters · filed 2012-02-10
-$10.48M
derived: sum of 3 quarters · filed 2012-02-10
2010-09-30$332.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19
$540.01K
derived: sum of 2 quarters · filed 2011-12-19
-$1.05M
10-K · filed 2011-12-19
2010-06-30$207.51K
10-Q · filed 2011-08-12
-$1.38M
10-Q · filed 2011-08-12